Infliximab as a therapy for idiopathic hypereosinophilic syndrome

Arch Dermatol. 2007 Sep;143(9):1110-2. doi: 10.1001/archderm.143.9.1110.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged, 80 and over
  • Anti-Inflammatory Agents / therapeutic use*
  • Antibodies, Monoclonal / therapeutic use*
  • Female
  • Humans
  • Hypereosinophilic Syndrome / diagnosis
  • Hypereosinophilic Syndrome / drug therapy*
  • Infliximab
  • Skin Diseases / diagnosis
  • Skin Diseases / drug therapy*

Substances

  • Anti-Inflammatory Agents
  • Antibodies, Monoclonal
  • Infliximab